Skip to main content
. Author manuscript; available in PMC: 2012 Apr 10.
Published in final edited form as: J Control Release. 2010 Dec 28;151(1):95–101. doi: 10.1016/j.jconrel.2010.12.011

Figure 2.

Figure 2

Schematics of the treatment protocol used to evaluate the potential use of the biopolymeric platform for combination gene (pSR39) and siRNA (BCL2) therapy.